Brief: Curevac: Positive Data In Older Adults From Covid-19, Flu MRNA Vaccine Development Programs

CureVac NV

30/01/2023 12:03

Jan 30 (Reuters) - Curevac Nv  5CV.DE :
    * EQS-NEWS: CUREVAC ANNOUNCES POSITIVE DATA IN OLDER ADULTS
FROM
COVID-19 AND FLU MRNA VACCINE DEVELOPMENT PROGRAMS
    * CONTINUED TECHNOLOGY PLATFORM VALIDATION WITH EXTENDED
PRELIMINARY DATA FROM OLDER ADULTS IN ONGOING PHASE 1 STUDIES IN
COVID-19 AND FLU
    * COVID-19: MONOVALENT MODIFIED MRNA CONSTRUCT CV0501
SUCCESSFULLY
BOOSTED ANTIBODY TITERS AGAINST BA.1 AND ANCESTRAL VARIANTS IN
ADULTS AGE ≥65
    * FLU: MONOVALENT MODIFIED MRNA CONSTRUCT FLU-SV-MRNA
ELICITED
ANTIBODIES APPROXIMATELY 2.3 TIMES THOSE OF LICENSED VACCINE
COMPARATOR IN ADULTS AGED 60-80
    * REAFFIRMING PLAN TO ADVANCE MODIFIED MRNA COVID-19 AND FLU
CANDIDATES TO NEXT STAGES OF CLINICAL DEVELOPMENT IN
COLLABORATION WITH GSK IN 2023

Further company coverage:  5CV.DE 
 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))